Nitipol Srimongkolpithak

Title: Nitipol Srimongkolpithak: Innovator in Quinazoline Compounds

Introduction

Nitipol Srimongkolpithak is a notable inventor based in London, GB. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on quinazoline compounds. His research focuses on the therapeutic applications of these compounds, which have the potential to impact various diseases.

Latest Patents

Nitipol holds a patent for "Quinazoline compounds and their use in therapy." This invention relates to quinazoline compounds of Formula (I), which are inhibitors of the histone lysine methyltransferase (HKMTase) EZH2. The patent outlines the uses of such compounds as medicaments, especially in treating diseases or disorders where inhibition of EZH2 provides a therapeutic or prophylactic effect. He has 1 patent to his name.

Career Highlights

Throughout his career, Nitipol has worked with prominent organizations, including Imperial Innovations Limited and Emory University. His work in these institutions has allowed him to advance his research and collaborate with other experts in the field.

Collaborations

Nitipol has collaborated with notable individuals such as Robert Albert Brown and Matthew John Fuchter. These partnerships have contributed to the development and refinement of his innovative ideas.

Conclusion

Nitipol Srimongkolpithak is a distinguished inventor whose work on quinazoline compounds showcases his commitment to advancing medical therapies. His contributions to the field are significant and continue to influence research in medicinal chemistry.